BXQ-350

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameBXQ-350
Drug Alias NameSapC-DOPSSaposin C coupled-phospholipid dioleoylphosphatidylserineBXQ-350
ClassificationSmall molecules > Synthetic peptideDiagnostic agent (In vivo)
Mechanisms of ActionApoptosis inducers
TargetsNot applicable
Therapy Area/IndicationsDiffuse midline gliomaPeripheral Nervous System DiseasesNervous System Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBexion
China Registration ClassN/A

Develop Information

Active CompaniesBexion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System DiseasesColorectal Neoplasms
Inactive IndicationsDiffuse midline gliomaNervous System DiseasesDiffuse Intrinsic Pontine Glioma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A